Clinical trial
Gene Therapy in Treating Patients With Metastatic Melanoma
NCT00005943 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00005943 |
|---|---|
| Title | Gene Therapy in Treating Patients With Metastatic Melanoma |
| Official title | A Phase I Study Using Direct Combination DNA Injections for the Immunotherapy of Metastatic Melanoma |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | aldesleukin, staphylococcal enterotoxin B |
| Start date | Feb 1, 2000 |
| Primary completion | Sep 1, 2001 |
| Completion | Sep 1, 2001 |
| First posted | Apr 9, 2004 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: